(Q33357689)

26 July 2017

8 references

13 March 2019

20 June 2019

19 June 2019

25 June 2019

22 July 2019

19 September 2019

23 December 2020

28 October 2022

0 references

Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis (English)

1 reference

intrauterine growth restriction

26 July 2017

6 references

13 March 2019

20 June 2019

19 June 2019

25 June 2019

22 July 2019

19 September 2019

8 references

13 March 2019

20 June 2019

19 June 2019

25 June 2019

22 July 2019

19 September 2019

23 December 2020

28 October 2022

preventive health services

1 reference

biomedical investigative technique

22 July 2019

1 reference

19 September 2019

1 reference

23 December 2020

1 reference

1 reference

Rachel K Morris

1

0 references

Gerben ter Riet

object named as

Gerben Ter Riet

6

0 references

Jos Kleijnen

5

object named as

Jos Kleijnen

1 reference

26 July 2017

Khalid S Khan

9

1 reference

ORCID Public Data File 2021

Ben W. Mol

7

object named as

Ben W Mol

1 reference

26 July 2017

Jeltsje S Cnossen

2

1 reference

26 July 2017

Marloes Langejans

3

1 reference

26 July 2017

Stephen C Robson

4

1 reference

26 July 2017

Joris A M van der Post

8

1 reference

26 July 2017

language of work or name

1 reference

4 August 2008

9 references

BMC Pregnancy and Childbirth

26 July 2017

13 March 2019

20 June 2019

19 June 2019

25 June 2019

22 July 2019

19 September 2019

23 December 2020

28 October 2022

9 references

26 July 2017

13 March 2019

20 June 2019

19 June 2019

25 June 2019

22 July 2019

19 September 2019

23 December 2020

28 October 2022

8

1 reference

26 July 2017

issue

1

1 reference

17 June 2019

page(s)

33

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

8 references

13 March 2019

20 June 2019

19 June 2019

25 June 2019

22 July 2019

19 September 2019

23 December 2020

on focus list of Wikimedia project

28 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

We should not pool diagnostic likelihood ratios in systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The value of predicting restriction of fetal growth and compromise of its wellbeing: Systematic quantitative overviews (meta-analysis) of test accuracy literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Prediction of pre-eclampsia: a protocol for systematic reviews of test accuracy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

No role for quality scores in systematic reviews of diagnostic accuracy studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The developmental origins of chronic adult disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

World Health Organization systematic review of screening tests for preeclampsia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Diagnostic tests 4: likelihood ratios

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Development and validation of methods for assessing the quality of diagnostic accuracy studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Association between first trimester maternal serum pregnancy associated plasma protein-A and adverse pregnancy outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The addition of activin A and inhibin A measurement to uterine artery Doppler velocimetry to improve the early prediction of pre-eclampsia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Elevated maternal mid-trimester chorionic gonadotropin > or =4 MoM is associated with fetal cerebral blood flow redistribution

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Reporting of measures of accuracy in systematic reviews of diagnostic literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Systematic reviews to evaluate diagnostic tests

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Prediction of smallness for gestational age by maternal serum human chorionic gonadotropin levels and by uterine artery Doppler study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The detection, investigation and management of hypertension in pregnancy: full consensus statement

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Empirical evidence of design-related bias in studies of diagnostic tests

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Birthweight and the risk for type 2 diabetes mellitus in adult women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Elevated midtrimester maternal serum hCG in chromosomally normal pregnancies is associated with preeclampsia and velamentous umbilical cord insertion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Associations between adverse perinatal outcome and serially obtained second- and third-trimester maternal serum alpha-fetoprotein measurements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Disturbed zinc metabolism and reduced birthweight related to raised maternal serum alpha-fetoprotein in normal human pregnancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Unexplained elevated maternal serum α-fetoprotein levels and perinatal outcome in an urban clinic population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Maternal serum alpha-fetoprotein levels in low birth weight singleton pregnancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Outcome of pregnancies associated with raised serum and normal amniotic fluid alpha fetoprotein concentrations.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Data from an alpha-fetoprotein pilot screening program in Maine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Anthropometric assessment of nutritional status in newborn infants. Discriminative value of mid arm circumference and of skinfold thickness

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Fetal growth achievement and neurodevelopmental disability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Can low birth weight after elevated maternal serum alpha-fetoprotein be explained by maternal weight?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

High maternal serum alpha-fetoprotein and low birthweight. A study concerning possible correlation between maternal weight, smoking, and serum alpha-fetoprotein and subsequent birthweight and gestational age.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Association between unaccountably high maternal alpha feto-protein and increased fetal risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Ponderal index: a better definition of the 'at risk' group with intrauterine growth problems than birth-weight for gestational age in term infants

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Relationship Between Second Trimester Maternal Serum Alpha-Fetoprotein and Umbilical Artery Doppler Velocimetry and Their Association with Preterm Delivery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Study of the relationship between elevated maternal serum alpha-fetoprotein and adverse pregnancy outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Elevated maternal serum alpha-fetoprotein levels and maternal risk factors. Their association with pregnancy complications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Maternal serum alpha-fetoprotein levels as an index of fetal risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Maternal serum-alpha-fetoprotein and low birth-weight

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Birth weight in relation to morbidity and mortality among newborn infants

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Guidelines for meta-analyses evaluating diagnostic tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Customized birthweight centiles predict SGA pregnancies with perinatal morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Relationship between customised birthweight centiles and neonatal anthropometric features of growth restriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Evidence of bias and variation in diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Quad screen as a predictor of adverse pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Early prediction of uteroplacental complications of pregnancy using Doppler ultrasound, placental function tests and combination testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Isolated low second-trimester maternal serum β-human chorionic gonadotropin is not associated with adverse pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Pregnancy outcome in Hispanic patients with unexplained positive triple marker screening for Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

The implications of a false positive second-trimester serum screen for Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Predicting complications of pregnancy with first-trimester maternal serum free-betahCG, PAPP-A and inhibin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Abnormal maternal serum alpha fetoprotein and pregnancy outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

World Health Organization Systematic Review of Screening Tests for Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Measuring blood pressure in pregnant women: a comparison of direct and indirect methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2393-8-33

Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Perinatal outcome in SGA births defined by customised versus population-based birthweight standards

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Serum screening for Down syndrome and adverse pregnancy outcomes: a case-controlled study

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

The potential of mid-trimester maternal plasma alpha-fetoprotein measurement in predicting infants of low birth weight

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Maternal serum alpha-fetoprotein and birth weight

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Mid-trimester levels of alphafetoprotein in the screening of low birthweight.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

Placental protein measurements in complicated pregnancies. I. Intrauterine growth retardation

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533288

First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications

31 October 2018

1 reference

12 December 2020

First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome

1 reference

12 December 2020

The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications

1 reference

12 December 2020

Unexplained elevated maternal serum alpha-fetoprotein in singleton pregnancies as a predictor of fetal risk

1 reference

12 December 2020

Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening

1 reference

12 December 2020

Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler

1 reference

12 December 2020

Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome

1 reference

12 December 2020

Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein

1 reference

12 December 2020

Workshop summary: fetal growth: its regulation and disorders

1 reference

12 December 2020

Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk

1 reference

12 December 2020

Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry

1 reference

12 December 2020

[Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation]

1 reference

12 December 2020

Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies

1 reference

12 December 2020

Second trimester serum free beta human chorionic gonadotrophin levels as a predictor of pre-eclampsia

1 reference

12 December 2020

Validity in nulliparas of increased beta-human chorionic gonadotrophin at mid-term for predicting pregnancy-induced hypertension complicated with proteinuria and intrauterine growth retardation

1 reference

12 December 2020

Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome

1 reference

12 December 2020

Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies

1 reference

12 December 2020

Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry

1 reference

12 December 2020

Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia

1 reference

12 December 2020

Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia

1 reference

12 December 2020

The effects on fetal development of high alpha-fetoprotein and maternal smoking

1 reference

12 December 2020

Pregnancy outcomes following false-positive multiple marker screening tests

1 reference

12 December 2020

Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects

1 reference

12 December 2020

Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery

1 reference

12 December 2020

Maternal Serum Triple Analyte Screening and Adverse Pregnancy Outcome

1 reference

12 December 2020

The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein

1 reference

12 December 2020

Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler

1 reference

12 December 2020

Alpha-fetoprotein, vaginal bleeding and pregnancy risk

1 reference

12 December 2020

Prediction of pregnancy outcome with single versus serial maternal serum a-fetoprotein tests

1 reference

12 December 2020

Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol

1 reference

12 December 2020

Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes

1 reference

12 December 2020

Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers

1 reference

12 December 2020

Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin

1 reference

12 December 2020

Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women

1 reference

12 December 2020

The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia

1 reference

12 December 2020

Positive serum screening for fetal Down syndrome does not predict adverse pregnancy outcome in absence of fetal aneuploidy

1 reference

12 December 2020

Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome

1 reference

12 December 2020

Predictive value of early human chorionic gonadotrophin serum profiles for fetal growth retardation

1 reference

12 December 2020

First-trimester screening for trisomies 21 and 18

1 reference

12 December 2020

Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels

1 reference

12 December 2020

Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome

1 reference

12 December 2020

Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction

1 reference

12 December 2020

An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome

1 reference

12 December 2020

Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies

1 reference

12 December 2020

Elevated second-trimester free beta-hCG as an isolated finding and pregnancy outcomes

1 reference

12 December 2020

Effectiveness of interventions to prevent or treat impaired fetal growth

1 reference

12 December 2020

Analysis of mid-trimester corticotrophin-releasing hormone and alpha-fetoprotein concentrations for predicting pre-eclampsia

1 reference

12 December 2020

Significance of raised maternal serum alpha-fetoprotein in singleton pregnancies with normally formed fetuses

1 reference

12 December 2020

[Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results]

1 reference

12 December 2020

Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up

1 reference

12 December 2020

Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome

1 reference

12 December 2020

Fetal malnutrition: Its incidence, causes, and effects

1 reference

12 December 2020

Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation

1 reference

12 December 2020

Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia

1 reference

12 December 2020

Inhibin-A and superimposed preeclampsia in women with chronic hypertension

1 reference

12 December 2020

Predicting neonatal outcomes: birthweight, body mass index or ponderal index?

1 reference

12 December 2020

First trimester inhibin-A concentrations and later development of preeclampsia

1 reference

12 December 2020

Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of pre-eclampsia

1 reference

12 December 2020

Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation

1 reference

12 December 2020

The efficacy of first-trimester PAPP-A and free beta hCG levels for predicting adverse pregnancy outcome

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2393-8-33

1 reference

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2393-8-33

9 September 2019

1 reference

26 July 2017

1 reference